§ 13F · FUND PROFILE
Lion Point Capital, LP.
AUM · $18M (13F)Positions · 27Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$2M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | CUE | CUE BIOPHARMA INC | 53K | $2M | 8.0% | NEW |
| 2 | PRAX | PRAXIS PRECISION MEDICINES I | 4K | $1M | 7.1% | ±0% |
| 3 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 68K | $1M | 6.3% | ±0% |
| 4 | FENC | FENNEC PHARMACEUTICALS INC | 112K | $1M | 5.8% | ±0% |
| 5 | RPRX | ROYALTY PHARMA PLC | 21K | $1M | 5.7% | ±0% |
| 6 | CMPS | COMPASS PATHWAYS PLC | 80K | $1M | 5.4% | ±0% |
| 7 | MIST | MILESTONE PHARMACEUTICALS IN | 820K | $1M | 5.3% | ±0% |
| 8 | BNTC | BENITEC BIOPHARMA INC | 62K | $830K | 4.0% | ±0% |
| 9 | SNDX | SYNDAX PHARMACEUTICALS INC | 36K | $787K | 3.8% | ±0% |
| 10 | BHVN | BIOHAVEN LTD | 52K | $769K | 3.7% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE LION SIGNAL
AC read
Lion Point Capital, LP is a Other fund managing $18 million in assets. The fund runs a focused portfolio of just 27 positions.
Read the full dossier →